Breaking News
1 day ago
Simantini Singh Deo
Immuthera and PolTREG appoint top diabetes and immunotherapy experts to new Scientific Advisory Board for Treg therapy development.
Simantini Singh Deo
AB Science receives FDA and EMA clearance to launch Phase 3 trial of masitinib for biomarker-selected mCRPC patients.
Simantini Singh Deo
FDC’s Rajesh Bhattacharjee shares his PAC model and vision for pharma training that drives business growth and employee retention.
Simantini Singh Deo
Essential Pharma appoints Simon Ramsden as CFO and Rob Smith as CTO to strengthen growth and operational strategy.
Simantini Singh Deo